Find Guanfacine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

REF. STANDARDS OR IMPURITIES

0

EDQM

0

JP

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

234RELATED EXCIPIENT COMPANIES

387EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 29110-48-3, Guanfacine hcl, Tenex, Intuniv, Guanfacine (hydrochloride), N-carbamimidoyl-2-(2,6-dichlorophenyl)acetamide hydrochloride
Molecular Formula
C9H10Cl3N3O
Molecular Weight
282.5  g/mol
InChI Key
DGFYECXYGUIODH-UHFFFAOYSA-N
FDA UNII
PML56A160O

Guanfacine
A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
1 2D Structure

Guanfacine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide;hydrochloride
2.1.2 InChI
InChI=1S/C9H9Cl2N3O.ClH/c10-6-2-1-3-7(11)5(6)4-8(15)14-9(12)13;/h1-3H,4H2,(H4,12,13,14,15);1H
2.1.3 InChI Key
DGFYECXYGUIODH-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl.Cl
2.2 Other Identifiers
2.2.1 UNII
PML56A160O
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Bs 100 141

2. Bs-100-141

3. Bs100141

4. Estulic

5. Guanfacine

6. Guanfacine Monohydrochloride

7. Hydrochloride, Guanfacine

8. Lon798

9. Monohydrochloride, Guanfacine

10. Tenex

2.3.2 Depositor-Supplied Synonyms

1. 29110-48-3

2. Guanfacine Hcl

3. Tenex

4. Intuniv

5. Guanfacine (hydrochloride)

6. N-carbamimidoyl-2-(2,6-dichlorophenyl)acetamide Hydrochloride

7. Estulic

8. Bs 100-141

9. 29520-14-7

10. N-(aminoiminomethyl)-2,6-dichlorobenzeneacetamide Hydrochloride

11. Spd503

12. N-amidino-2-(2,6-dichlorophenyl)acetamide Hydrochloride

13. N-amidino-2-(2,6-dichlorophenyl)acetamide Monohydrochloride

14. Guafacine Hydrochloride

15. Bs-100-141

16. Benzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-, Monohydrochloride

17. Spd 503

18. Mls000069745

19. Pml56a160o

20. Smr000058453

21. 29110-48-3 (hcl)

22. Dsstox_cid_25157

23. Dsstox_rid_80708

24. Dsstox_gsid_45157

25. Connexyn

26. Lon 798

27. N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide;hydrochloride

28. Cas-29520-14-7

29. Guanfacinehcl

30. Tenex (tn)

31. Guanfacinehydrochloride

32. Sr-01000075893

33. Ncgc00015469-05

34. Einecs 249-443-3

35. N-(aminoiminomethyl)-2,6-dichlorophenylacetamide Monohydrochloride

36. Unii-pml56a160o

37. Spd-503

38. Prestwick_740

39. Guanfacine Hydrochloride (jan/usp)

40. Intuniv (tn)

41. Mfcd00798230

42. Guanfacine Hydrochloride [usan:usp:jan]

43. Opera_id_1928

44. N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide Hydrochloride

45. Benzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-, Hydrochloride (1:1)

46. G 1043

47. Schembl41681

48. Mls001077329

49. Mls002222252

50. [(2,6-dichlorophenyl)acetyl]guanidine Hydrochloride

51. Chebi:5559

52. Chembl1200494

53. Dtxsid2045157

54. Schembl15603414

55. Hms1569c19

56. Hms3747e15

57. Pharmakon1600-01505435

58. Bcp21710

59. N-(aminoiminomethyl)-2,6-dichloro-benzeneacetamide Hydrochloride

60. Tox21_110159

61. Tox21_500519

62. Guanfacine Hydrochloride [mi]

63. Nsc759121

64. S4693

65. Guanfacine Hydrochloride [jan]

66. Akos015966858

67. Akos030242245

68. Tox21_110159_1

69. Ccg-213439

70. Ccg-220339

71. Cs-1254

72. Guanfacine Hydrochloride [usan]

73. Lp00519

74. Guanfacine Hydrochloride [mart.]

75. Guanfacine Hydrochloride [vandf]

76. Guanfacine Hydrochloride [usp-rs]

77. Guanfacine Hydrochloride [who-dd]

78. Ncgc00015469-09

79. Ncgc00093914-01

80. Ncgc00093914-02

81. Ncgc00180965-01

82. Ncgc00261204-01

83. As-12253

84. Hy-17416

85. Guanfacine Hydrochloride, >=98% (hplc)

86. Bs100-141

87. Db-047525

88. Eu-0100519

89. Ft-0630546

90. Ft-0698181

91. G0414

92. Guanfacine Hydrochloride [orange Book]

93. D00606

94. Guanfacine Hydrochloride [usp Monograph]

95. T72238

96. A826918

97. J-017395

98. S-877503

99. Sr-01000075893-1

100. Sr-01000075893-3

101. Sr-01000075893-6

102. Q27286641

103. N-carbamimidoyl-2-(2,6-dichlorophenyl)-acetamide Hydrochloride

104. Guanfacine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

105. Guanfacine Hydrochloride, United States Pharmacopeia (usp) Reference Standard

106. N-[bis(azanyl)methylidene]-2-[2,6-bis(chloranyl)phenyl]ethanamide Hydrochloride

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 282.5 g/mol
Molecular Formula C9H10Cl3N3O
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count1
Rotatable Bond Count2
Exact Mass280.988945 g/mol
Monoisotopic Mass280.988945 g/mol
Topological Polar Surface Area81.5 Ų
Heavy Atom Count16
Formal Charge0
Complexity256
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameGuanfacine hydrochloride
Drug LabelTenex (guanfacine hydrochloride) is a centrally acting antihypertensive with 2-adrenoceptor agonist properties in tablet form for oral administration. The chemical name of Tenex (guanfacine hydrochloride) is N-amidino- 2-(2,6-dichlorophenyl) acetam...
Active IngredientGuanfacine hydrochloride
Dosage FormTablet, extended release; Tablet
Routeoral; Oral
Strengtheq 4mg base; eq 2mg base; 1mg; eq 1mg base; eq 3mg base; 4mg; 2mg; 3mg
Market StatusTentative Approval; Prescription
CompanyTwi Pharms; Epic Pharma; Teva Pharms Usa; Sandoz; Watson Labs; Actavis Elizabeth; Amneal Pharm; Mylan

2 of 4  
Drug NameTenex
PubMed HealthGuanfacine (By mouth)
Drug ClassesAntihypertensive, Cardiovascular Agent, Central Nervous System Agent
Drug LabelTenex (guanfacine hydrochloride) is a centrally acting antihypertensive with 2-adrenoceptor agonist properties in tablet form for oral administration. The chemical name of Tenex (guanfacine hydrochloride) is N-amidino- 2-(2,6-dichlorophenyl) acetam...
Active IngredientGuanfacine hydrochloride
Dosage FormTablet
RouteOral
Strengtheq 2mg base; eq 1mg base
Market StatusPrescription
CompanyPromius Pharma

3 of 4  
Drug NameGuanfacine hydrochloride
Drug LabelTenex (guanfacine hydrochloride) is a centrally acting antihypertensive with 2-adrenoceptor agonist properties in tablet form for oral administration. The chemical name of Tenex (guanfacine hydrochloride) is N-amidino- 2-(2,6-dichlorophenyl) acetam...
Active IngredientGuanfacine hydrochloride
Dosage FormTablet, extended release; Tablet
Routeoral; Oral
Strengtheq 4mg base; eq 2mg base; 1mg; eq 1mg base; eq 3mg base; 4mg; 2mg; 3mg
Market StatusTentative Approval; Prescription
CompanyTwi Pharms; Epic Pharma; Teva Pharms Usa; Sandoz; Watson Labs; Actavis Elizabeth; Amneal Pharm; Mylan

4 of 4  
Drug NameTenex
PubMed HealthGuanfacine (By mouth)
Drug ClassesAntihypertensive, Cardiovascular Agent, Central Nervous System Agent
Drug LabelTenex (guanfacine hydrochloride) is a centrally acting antihypertensive with 2-adrenoceptor agonist properties in tablet form for oral administration. The chemical name of Tenex (guanfacine hydrochloride) is N-amidino- 2-(2,6-dichlorophenyl) acetam...
Active IngredientGuanfacine hydrochloride
Dosage FormTablet
RouteOral
Strengtheq 2mg base; eq 1mg base
Market StatusPrescription
CompanyPromius Pharma

4.2 Drug Indication

Intuniv is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.

Intuniv must be used as a part of a comprehensive ADHD treatment programme, typically including psychological, educational and social measures.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Adrenergic alpha-2 Receptor Agonists

Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS. (See all compounds classified as Adrenergic alpha-2 Receptor Agonists.)


Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Central alpha-2 Adrenergic Agonist [EPC]; Adrenergic alpha2-Agonists [MoA]
5.3 ATC Code

C02AC02


USDMF

read-more
read-moreread-more

01

Jubilant Pharmova Ltd

India

USDMF

arrow
India Pharma Expo
Not Confirmed

01

India Pharma Expo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2016-11-18

Pay. Date : 2016-08-23

DMF Number : 28049

Submission : 2014-03-07

Status : Active

Type : II

blank

02

Medichem Sa

Spain

USDMF

arrow
India Pharma Expo
Not Confirmed

02

Medichem Sa

Spain
arrow
India Pharma Expo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2013-02-26

Pay. Date : 2013-02-05

DMF Number : 8590

Submission : 1990-06-12

Status : Active

Type : II

blank

03

India Pharma Expo
Not Confirmed

04

Procos Spa

Italy

USDMF

arrow
India Pharma Expo
Not Confirmed

04

Procos Spa

Italy
arrow
India Pharma Expo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2015-02-24

Pay. Date : 2014-06-19

DMF Number : 28312

Submission : 2014-05-19

Status : Active

Type : II

blank

05

Quimica Sintetica Sa

Spain

USDMF

arrow
India Pharma Expo
Not Confirmed

05

India Pharma Expo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-08-01

Pay. Date : 2014-07-29

DMF Number : 8661

Submission : 1990-07-12

Status : Active

Type : II

blank

06

India Pharma Expo
Not Confirmed

06

India Pharma Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 4985

Submission : 1983-04-22

Status : Inactive

Type : II

blank

07

India Pharma Expo
Not Confirmed

07

India Pharma Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 4784

Submission : 1982-12-06

Status : Inactive

Type : II

blank

08

India Pharma Expo
Not Confirmed

08

India Pharma Expo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-10-27

Pay. Date : 2014-07-15

DMF Number : 28443

Submission : 2014-08-04

Status : Active

Type : II

blank

09

India Pharma Expo
Not Confirmed

09

India Pharma Expo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2020-10-14

Pay. Date : 2020-09-08

DMF Number : 34653

Submission : 2020-03-26

Status : Active

Type : II

blank

10

India Pharma Expo
Not Confirmed
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

GUANFACINE HYDROCHLORIDE

NDC Package Code : 63190-0390

Start Marketing Date : 2008-12-16

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

GUANFACINE HYDROCHLORIDE

NDC Package Code : 63190-0250

Start Marketing Date : 2008-12-16

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

GUANFACINE HYDROCHLORIDE

NDC Package Code : 65372-1177

Start Marketing Date : 2014-03-04

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

GUANFACINE HYDROCHLORIDE

NDC Package Code : 53296-0024

Start Marketing Date : 2010-03-17

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (75kg/75kg)

Marketing Category : BULK INGREDIENT

blank

05

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

GUANFACINE HYDROCHLORIDE

NDC Package Code : 46016-2912

Start Marketing Date : 2013-07-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

blank

06

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

GUANFACINE HYDROCHLORIDE

NDC Package Code : 46016-2911

Start Marketing Date : 2022-03-24

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

blank

07

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

GUANFACINE HYDROCHLORIDE

NDC Package Code : 53069-0080

Start Marketing Date : 1995-01-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

GUANFACINE HYDROCHLORIDE

NDC Package Code : 53069-1150

Start Marketing Date : 2024-09-24

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

GUANFACINE HYDROCHLORIDE

NDC Package Code : 53747-096

Start Marketing Date : 2020-03-26

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

CHEMO

Spain
India Pharma Expo
Not Confirmed
arrow

CHEMO

Spain
arrow
India Pharma Expo
Not Confirmed

Guanfacine

About the Company : More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, ...

More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, and starts business activities trading with pharmaceutical raw materials. In the 80's, the company expanded its operations into the Industrial Business, developing and manufacturing active pharmaceutical ingredients (APIs) in Italy (Industriale Chimica) and in Spain (Quimica Sintetica). In the 90's, CHEMO starts developing and manufacturing high quality and technology finished dosage forms (FDFs).
blank

02

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

Guanfacine

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Excipients, Herbal extracts, Formulation of Chinese & Western Medicine. With abundant economic strength, the group has successfully developed to a pharmaceutical group enterprise wich intergrets operation of medicine & related products, processing & manufacturing, and importation & exportation together.
blank

03

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

Guanfacine

About the Company : Harman Finochem Limited is a leading India-based Pharmaceutical Company which specializes in the manufacture and export of more than 45 Active Pharmaceutical Ingredients (APls) of ...

Harman Finochem Limited is a leading India-based Pharmaceutical Company which specializes in the manufacture and export of more than 45 Active Pharmaceutical Ingredients (APls) of which 10 are Essential Drugs as per the WHO Model List. We deliver top quality products to more than 35 countries across the globe. Harman Finochem ensures that its customers worldwide are delighted by receiving APl’s which are safe, efficient and of highest quality. We adhere to principles of cGmp and our team at all levels is committed to achieving this corporate excellence goal.
blank

04

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

Guanfacine

About the Company : Jubilant Life Sciences Limited, is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmace...

Jubilant Life Sciences Limited, is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients. It also provides services in Contract Manufacturing of Sterile Injectables and Drug Discovery and Development. The Company’s strength lies in its unique offerings of Pharmaceutical and Life Sciences products and services across the value chain. Our success is an outcome of strategic focus on the pharmaceuticals and life sciences industry, moving up the pharmaceutical value chain for products.
blank

05

Procos

Italy
India Pharma Expo
Not Confirmed
arrow

Procos

Italy
arrow
India Pharma Expo
Not Confirmed

Guanfacine

About the Company : Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients...

Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry. Our core business sectors include custom synthesis and Generic API manufacturing. The manufacturing site is located in Cameri, Italy. This 110,000 sq. meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA.
blank

06

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

Guanfacine

About the Company : Torrent Pharma is part of 3 billion USD Torrent group; we are leading conglomerate from India, having presence across 40 countries including USA, Brazil, Europe, and Mexico & India...

Torrent Pharma is part of 3 billion USD Torrent group; we are leading conglomerate from India, having presence across 40 countries including USA, Brazil, Europe, and Mexico & India. Over the years, Torrent forayed into Dermatology & Oncology segment for which Torrent is actively looking for partners to provide Contract Manufacturing Services for India as well as Global markets. Torrent has state of the art manufacturing facility based in India and has capability to handle various types of Derma & Onco products with available capacity of more than 150 Mn units & 50 Mn units per Annum respectively.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

read-more
read-more

01

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

Guanfacine

Brand Name : Intuniv

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

02

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

Guanfacine

Brand Name : Intuniv

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

03

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

Guanfacine

Brand Name : Intuniv

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

India Pharma Expo
Not Confirmed
arrow
arrow
India Pharma Expo
Not Confirmed

Guanfacine

Brand Name : Intuniv

Dosage Form :

Dosage Strength :

Packaging : 28

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Solubilizers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Taste Masking

read-more
read-more

Topical

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Emulsifying Agents

read-more
read-more

Empty Capsules

read-more
read-more

Vegetarian Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Parenteral

read-more
read-more

Coloring Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 29110-48-3 / Guanfacine API manufacturers, exporters & distributors?

Guanfacine manufacturers, exporters & distributors 1

21

PharmaCompass offers a list of Guanfacine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Guanfacine manufacturer or Guanfacine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Guanfacine manufacturer or Guanfacine supplier.

API | Excipient name

Guanfacine

Synonyms

29110-48-3, Guanfacine hcl, Tenex, Intuniv, Guanfacine (hydrochloride), N-carbamimidoyl-2-(2,6-dichlorophenyl)acetamide hydrochloride

Cas Number

29110-48-3

Unique Ingredient Identifier (UNII)

PML56A160O

About Guanfacine

A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Guanfacine HCl Manufacturers

A Guanfacine HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Guanfacine HCl, including repackagers and relabelers. The FDA regulates Guanfacine HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Guanfacine HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Guanfacine HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Guanfacine HCl Suppliers

A Guanfacine HCl supplier is an individual or a company that provides Guanfacine HCl active pharmaceutical ingredient (API) or Guanfacine HCl finished formulations upon request. The Guanfacine HCl suppliers may include Guanfacine HCl API manufacturers, exporters, distributors and traders.

click here to find a list of Guanfacine HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Guanfacine HCl USDMF

A Guanfacine HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Guanfacine HCl active pharmaceutical ingredient (API) in detail. Different forms of Guanfacine HCl DMFs exist exist since differing nations have different regulations, such as Guanfacine HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Guanfacine HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Guanfacine HCl USDMF includes data on Guanfacine HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Guanfacine HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Guanfacine HCl suppliers with USDMF on PharmaCompass.

Guanfacine HCl JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Guanfacine HCl Drug Master File in Japan (Guanfacine HCl JDMF) empowers Guanfacine HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Guanfacine HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Guanfacine HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Guanfacine HCl suppliers with JDMF on PharmaCompass.

Guanfacine HCl WC

A Guanfacine HCl written confirmation (Guanfacine HCl WC) is an official document issued by a regulatory agency to a Guanfacine HCl manufacturer, verifying that the manufacturing facility of a Guanfacine HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Guanfacine HCl APIs or Guanfacine HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Guanfacine HCl WC (written confirmation) as part of the regulatory process.

click here to find a list of Guanfacine HCl suppliers with Written Confirmation (WC) on PharmaCompass.

Guanfacine HCl NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Guanfacine HCl as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Guanfacine HCl API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Guanfacine HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Guanfacine HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Guanfacine HCl NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Guanfacine HCl suppliers with NDC on PharmaCompass.

Guanfacine HCl GMP

Guanfacine HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Guanfacine HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Guanfacine HCl GMP manufacturer or Guanfacine HCl GMP API supplier for your needs.

Guanfacine HCl CoA

A Guanfacine HCl CoA (Certificate of Analysis) is a formal document that attests to Guanfacine HCl's compliance with Guanfacine HCl specifications and serves as a tool for batch-level quality control.

Guanfacine HCl CoA mostly includes findings from lab analyses of a specific batch. For each Guanfacine HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Guanfacine HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Guanfacine HCl EP), Guanfacine HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Guanfacine HCl USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty